Ignite Creation Date:
2024-05-05 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 9:50 AM
Study NCT ID:
NCT00689390
Status:
TERMINATED
Last Update Posted:
2018-09-11
First Post:
2008-05-27
Brief Title:
Three-year Follow-up of Participants After Administration of Boceprevir or Narlaprevir for the Treatment of Chronic Hepatitis C P05063
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-20
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-10-13
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-27
First Submit QC Date:
May 29 2008
Study First Post Date:
2008-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-10-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-13
Last Update Post Date:
2018-09-11
Last Update Post Date Type:
ACTUAL